Home › NDC Lookup › RxCUI directory › RxCUI 311982

Nilutamide 150 MG Oral Tablet — RxCUI 311982

RxNorm drug concept · Semantic clinical drug
RxCUI 311982 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311982
Official nameNilutamide 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nilutamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nilutamide is specifically approved to be used together with surgical removal of the testicles — not on its own for this purpose. The surgery cuts off the main source of testostero...
  • Why do I need surgery AND this pill? Can't the pill work on its own?
  • Yes, this is one of the most distinctive and common side effects of nilutamide. Over half of patients in one clinical trial reported trouble adapting when moving from a bright plac...
  • I'm having trouble seeing in the dark since starting this medication. Is that normal?
📖 Read our full Nilutamide guide →

🕸️ Concept Web — How Nilutamide 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nilutamide 150 MG Oral Tablet RxCUI 311982

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nilutamide 31805
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nilandron 218741
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nilutamide Oral Tablet 373082
    • Nilutamide Oral Product 1158946
    • Nilutamide Pill 1158947
    • Nilutamide Oral Tablet [Nilandron] 367745
    • Nilandron Oral Product 1183905
    • Nilandron Pill 1183906
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Nilutamide 150 MG 331558
    • Nilutamide 150 MG Oral Tablet [Nilandron] 284551
    • Nilutamide 150 MG [Nilandron] 574979

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nilutamide 150 MG SCDC · 331558
  • Nilutamide Oral Tablet SCDF · 373082
  • Nilutamide Oral Product SCDG · 1158946
  • Nilutamide Pill SCDG · 1158947

Brand-Name Concepts

  • Nilutamide 150 MG Oral Tablet [Nilandron] SBD · 284551
  • Nilutamide 150 MG [Nilandron] SBDC · 574979
  • Nilutamide Oral Tablet [Nilandron] SBDF · 367745
  • Nilandron Oral Product SBDG · 1183905
  • Nilandron Pill SBDG · 1183906
  • Nilandron BN · 218741

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 311982 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62559-0173-31 3 BLISTER PACK in 1 CARTON (62559-173-31) / 10 TABLET in 1... Nilutamide ANI Pharmaceuticals, Inc. 2016-07-18
Observed labelers: ANI Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.